(TheNewswire)
Calgary , Alberta – TheNewswire - May 1, 2023 – nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT)(OTC:NDATF) provides an operational update for its YMI machinelearning-based mental health assessment program and announcesinitiation of its clinical decision supportsystem ("CDSS") program. The Corporation reports that its YMI predictive mental health assessmentprogram is fully functional and is being marketed direct-to-consumers("B2C") in New York State and California State. Preliminarystatistics are expected at the end of May, 2023 which will helpprovide direction for B2C marketing and advertising channels. A YMIFree Trial is available to all at https://ymihealth.ca.
The Corporation further announces that it has initiatedthe search for a qualified third-party institution to conduct aclinical trial in preparation for launch of the clinical decisionsupport system ("CDSS") aspect of the YMI application. TheYMI CDSS is designed for primary physicians, including those in FamilyMedicine and General Practice, who are not fully trained in mentalhealth diagnosis and treatment, but are often the first point ofcontact with the mental health system for patients with mental healthconcerns. According to the AAMC* there are approximately 120,000 ofthese primary physicians in the United States. As part of the CDSSprogram, the Corporation will explore strategic relationships withelectronic medical records ("EMR") and electronic healthrecords ("EHR") companies that are seeking to add a mentalhealth aspect to their software offerings. EMR and EHR softwareplatforms are used to manage digital patient "charts" andare widely used by primary physicians. *(https://www.aamc.org/data-reports/workforce/data/active-physicians-us-doctor-medicine-us-md-degree-specialty-2019)
About YMI: YMIuses a holistic, evidence-based, objective data from whole lifeexperiences to predict why you are who you are, and applies thisknowledge towards a fuller understanding of how to improve your mentalwellbeing. After registering at ymihealth.ca (https://ymihealth.ca)users gain access to a private, in-depth survey that appliesmachine-learning using a person’s genetic expressions, childhoodenvironment, habits, phobias, lived experiences and lifestyle. Uponcompletion of the questionnaire YMI generates a personalized graphicreport predicting a person’s predisposition for seven mentalconditions including anxiety, depression, post-traumatic stressdisorder, obsessive compulsive disorder, alcoholism, and personalitydisorders both current and forward in time. The downloadable reportmay be used for reference as the user considers changes to theirlifestyle that may help improve their mental wellbeing and mentalhealth journey. The service also helps connect users with therapistswho are prepared to help with next steps, providing further clarityand treatment as required.
About nDatalyze Corp.: nDatalyze Corp. generates technology-based, health-relatedsolutions. It’s machine-learning processed, online consumer mentalhealth application known as “YMI” is based on the Corporation’sproprietary Reference Database consisting of >1200 biometricrecords complete with associated electroencephalogram (“EEG”)data. YMI has only recently begun its initial staged launch andaccordingly the Corporation cannot accurately predict if or when thisapplication will become a profit generator.
For Further Information, PleaseContact:
James Durward, President and CEO
Telephone: (403) 689-3901
Email: jimd@ndatalyze.com Website: https://ymihealth.ca
Neither the Canadian Securities Exchange nor itsRegulation Services Provider (as that term is defined in the policiesof the Canadian Securities Exchange) accepts responsibility for theadequacy or accuracy of this release. This news release does notconstitute an offer to sell or a solicitation of an offer to sell anyof the securities in the United States. The securities have not beenand will not be registered under the United States Securities Act of1933, as amended (the "U.S. Securities Act") or any statesecurities laws and may not be offered or sold within the UnitedStates or to U.S. Persons unless registered under the U.S. SecuritiesAct and applicable state securities laws or an exemption from suchregistration is available.
The information in this news release includes certaininformation and statements about management's view of future events,expectations, plans and prospects that constitute forward lookingstatements. These statements are based upon assumptions that aresubject to significant risks and uncertainties. Because of these risksand uncertainties and as a result of a variety of factors, the actualresults, expectations, achievements or performance may differmaterially from those anticipated and indicated by these forwardlooking statements. Any number of factors could cause actual results to differ materially from theseforward-looking statements as well as future results. Although theCorporation believes that the expectations reflected in forwardlooking statements are reasonable, it can give no assurances that theexpectations of any forward-looking statements will prove to becorrect. Except as required by law, the Corporation disclaims anyintention and assumes no obligation to update or revise any forwardlooking statements to reflect actual results, whether as a result ofnew information, future events, changes in assumptions, changes infactors affecting such forward looking statements or otherwise.
Copyright (c) 2023 TheNewswire - All rights reserved.